> Short term at least, the outlook in the markets for orthopedics services and devices appears bright, according to Raj Denhoy, director of equity research at Thomas Weisel Partners. FierceHealthFinance
> Rehab services provider HealthSouth Corp,. has reported a dramatic drop in net income of $6.6 million, or less than a penny a share for Q3 compared to $267.6 million, or $3.13 a share, for the same period last year. FierceHealthFinance
> Sweden's AnaMar Medical has raised SEK 75 million ($9.6 million) to fund a phase I study of AM240 MCR for rheumatoid arthritis. The funds are provided through a rights issue guaranteed by AnaMar's principal owner Koncentra Holding. FiercePharma
> Just hours after Sanofi-Aventis pulled the plug on its clinical trials for the diet drug Acomplia, Pfizer followed suit and called a halt on its development of an experimental weight loss drug belonging to the same class of drugs. FierceBiotech
And Finally... Obama sure knows how to party! Article